Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 03, 2015 8:07 PM ET

Healthcare Equipment and Supplies

Company Overview of NeoTract, Inc.

Company Overview

NeoTract, Inc. develops and manufactures medical devices for urologists. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was incorporated in 2004 and is based in Pleasanton, California.

4473 Willow Road

Suite 100

Pleasanton, CA 94588

United States

Founded in 2004

Phone:

925-401-0700

Fax:

925-401-0697

Key Executives for NeoTract, Inc.

Chief Executive Officer, President and Director
Co-Founder and Chairman
Age: 51
Founder, Chief Technical Officer and Director
Co-Founder and Vice President of Research & Development
Chief Financial Officer
Compensation as of Fiscal Year 2015.

NeoTract, Inc. Key Developments

NeoTract, Inc. Presents at Medical Device Conference 2015, Jun-25-2015 through Jun-26-2015

NeoTract, Inc. Presents at Medical Device Conference 2015, Jun-25-2015 through Jun-26-2015. Venue: Palace Hotel, 2 New Montgomery Street, San Francisco, California, United States. Presentation Date & Speakers: Jun-26-2015, David Amerson, Chief Executive Officer, President and Director.

NeoTract, Inc. Presents at International Business Forum 14th Annual MedTech Investing Conference, May-06-2015 02:20 PM

NeoTract, Inc. Presents at International Business Forum 14th Annual MedTech Investing Conference, May-06-2015 02:20 PM. Venue: Loews Minneapolis Hotel, 601, 1st Ave North, Minneapolis, MN 55403, United States. Speakers: Dave Amerson, President & CEO.

NeoTract Announces Positive Guidelines from European Association of Urology for Minimally Invasive Treatment for Benign Prostatic Hyperplasia

NeoTract, Inc. announced that the European Association of Urology (EAU) has given the UroLift® System a positive recommendation for the treatment of patients with benign prostatic hyperplasia (BPH) in its newly updated ‘Guidelines for the Management of Non-Neurogenic Male Lower Urinary Tract Symptoms, Including Benign Prostatic Obstruction,’ published in European Urology The guidelines assist practicing urologists in Europe in making informed decisions based on the highest-quality scientific data. The guidelines and recommendations were based on a rigorous systematic review of the published literature on the UroLift System, performed by a panel of experts with urological and epidemiological backgrounds. The review panel graded the clinical evidence supporting the UroLift device Level 1-b, the second-highest level of evidence, denoting evidence obtained from at least one properly designed randomized controlled trial that suggests that the benefits of the clinical service outweigh the potential risks. Three-year results of the L.I.F.T. IDE Study, a multi-center, randomized, blinded U.S. clinical trial, as well as one-year results from the randomized BPH-6 European multi-center randomized study comparing UroLift to transurethral resection of the prostate (TURP), will be presented at the American Urological Association’s annual conference taking place May 15-19 in New Orleans. The UroLift device has received regulatory clearance in the United States, is CE marked in Europe, and is currently available in Denmark, Finland, France, Germany, Italy, The Netherlands, Norway, Spain, Sweden, Turkey and the United Kingdom.

Similar Private Companies By Industry

Company Name Region
Bioabsorbable Vascular Solutions, Inc. United States
E.V.A. Corporation United States
Carbon Medical Technologies, Inc. United States
New Health Sciences Inc. United States
Clear Guide Medical, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NeoTract, Inc., please visit www.neotract.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.